Tetracycline
Thông số
60-54-8Số CAS
(4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamideTên IUPAC
C22H24N2O8Công thức hóa học
444.4 g/molKhối lượng phân tử
tetracycline; 60-54-8; Deschlorobiomycin; Tsiklomitsin; Tetraciclina; Tetracyclinum; Sumycin; Abramycin; Ambramycin; Panmycin; Tetracyclin; Tetracyn; Cyclopar; Liquamycin; Omegamycin; Tetrazyklin; Achromycin V; Agromicina; Ambramicina; Criseociclina; Purocyclina; Tetradecin; Tetraverine; Tsiklomistsin; Vetacyclinum; Tetrabon; Tetrafil; Cefracycline; Abricycline; Biocycline; Ciclibion; Copharlan; Cyclomycin; Democracin; Lexacycline; Limecycline; Mericycline; Micycline; Orlycycline; Roviciclina; Solvocin; Tetracycl; Amycin; Veracin; Tetracycline HCl; SK-Tetracycline; Tetracycline II; Tetra-Co; Tetracycline I; Bio-tetra; CCRIS 9483; (4S,4aS,5aS,6S,12aS)-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide; DTXSID7023645; Piracaps (base); Centet (base); (4S,4aS,5aS,12aS)-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide; NSC-108579; Cefracycline suspension; Liquamycin (Veterinary); F8VB5M810T; 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S,4aS,5aS,6S,12aS)-; Tetracycline base; CHEBI:27902; Tetracycline (internal use); Supramycin; Vetquamycin-324 (free base); MFCD00151232; (4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide; E701; Achromycin (naphthacene derivative); (4S,4aS,5aS,6S,12aS)-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide; T-125; HSDB 3188; 6-Methyl-1,11-dioxy-2-naphthacenecarboxamide; Tetracyclinum [INN-Latin]; Tetraciclina [INN-Spanish]; Sumycin (TN); Tetracycline & VRC3375; UNII-F8VB5M810T; Economycin; Vetquamycin; Brodspec; Tetracycline (JAN/USP/INN); SR-01000000212; NSC108579; Tetrabid Organon; Ala-Tet; Tetracycline [USP:INN:BAN:JAN]; (4S,4aS,5aS,6S,12aS)-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide; 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-; 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S-(4alpha,4aalpha,5aalpha,6beta,12aalpha))-; EINECS 200-481-9; 60-54-8 (FREE BASE); Spectrum_001034; Tetracycline (Standard); Prestwick0_000140; Prestwick1_000140; Prestwick2_000140; Prestwick3_000140; Spectrum2_001329; Spectrum3_000565; Spectrum4_000352; Spectrum5_001112; TETRACYCLINE [MI]; TETRACYCLINE [INN]; TETRACYCLINE [JAN]; EC 200-481-9; TETRACYCLINE [HSDB]; SCHEMBL3098; TETRACYCLINE [VANDF]; BSPBio_000220; BSPBio_001950; KBioGR_000783; KBioSS_001514; TETRACYCLINE [MART.]; BIDD:GT0653; DivK1c_000827; Oxytetracycline EP Impurity B; SCHEMBL537050; TETRACYCLINE [WHO-DD]; SPBio_001457; SPBio_002159; BPBio1_000242; DTXCID703645; orb1224496; orb1310175; SCHEMBL2116649; SCHEMBL2116661; SCHEMBL21271987; SCHEMBL29349464; SCHEMBL29734343; GTPL10927; HY-A0107R; KBio1_000827; KBio2_001514; KBio2_004082; KBio2_006650; KBio3_001450; Tetracycline - Bio-X trade mark; TETRACYCLINE [GREEN BOOK]; NINDS_000827; DTXSID201371250; HMS2090B04; TETRACYCLINE [ORANGE BOOK]; Tetracycline, >=98.0% (NT); TETRACYCLINE [EP MONOGRAPH]; TETRACYCLINE [USP IMPURITY]; 2-NAPHTHACENECARBOXAMIDE, 4-(DIMETHYLAMINO)-1,4,4A,5,5A,6,11,12A-OCTAHYDRO-3,6,10,12,12A-PENTAHYDROXY-6-METHYL-1,11-DIOXO-, (4S-(4.ALPHA.,4A.ALPHA.,5A.ALPHA.,6.BETA.,12A.ALPHA.))-; HY-A0107; PYLERA COMPONENT TETRACYCLINE; RKL10088; TETRACYCLINE [USP MONOGRAPH]; Tetracycline, >=88.0% (HPLC); Tox21_300150; BDBM50237605; EBC-12827; T0912L; AKOS024277860; AKOS026749977; CS-8188; DB00759; Tetracycline dried down 2.5 microg/mL; CAS-60-54-8; IDI1_000827; NCGC00017323-03; NCGC00017323-04; NCGC00017323-05; NCGC00017323-07; NCGC00017323-14; NCGC00017323-15; NCGC00017323-16; NCGC00142507-02; NCGC00254063-01; 4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,1 0,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide; BT166207; DA-68063; ST019403; SBI-0051530.P003; LYMECYCLINE IMPURITY H [EP IMPURITY]; NS00000577; C06570; D00201; EN300-374118; AB00053550-04; AB00053550_05; AB00053550_06; Q193045; SR-01000000212-3; Oxytetracycline EP Impurity B; Lymecycline EP Impurity H; Z2144222809; OXYTETRACYCLINE HYDROCHLORIDE IMPURITY B [EP IMPURITY]; (4S,4aS,5aS,6S,12aR)-2-carbamoyl-4-(dimethylammonio)-6,10,11,12a-tetrahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracen-1-olate; (4S,6S,12aS,4aS,5aS)-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,1 1-dioxo-4,5,6,12a,4a,5a-hexahydronaphthacene-2-carboxamideTên gọi khác
